August 26, 2020
August 26, 2020 – The U.S. FDA has removed a black box warning for canagliflozin-containing products
regarding an increased risk of amputation. The warning was originally added to the drugs
- Have any questions?
- +1-888-INTL-SOS
- support@globalreachhealth.com
Pharmacy Benefits Management
August 25, 2020
August 25, 2020 – The U.S. FDA has approved Cystadrops® (cysteamine ophthalmic solution) 0.37%, manufactured by Recordati Rare Diseases, to treat corneal cystine crystal deposits in
August 25, 2020
August 25, 2020 – The U.S. FDA has approved Albuterol Sulfate Inhalation Aerosol 90mcg (base)/
actuation, manufactured by Lupin, as a generic for Teva’s ProAir® HFA. The product is
August 25, 2020
August 25, 2020 – RLC Labs has issued a voluntary recall of all lots within expiry of Nature-Throid® (Thyroid
USP Tablets) and WP Thyroid® (Thyroid USP Tablets). The manufacturer has found that
August 24, 2020
August 24, 2020 – The U.S. FDA has approved an expanded indication for Mirena® (levonorgestrel)
intrauterine device (IUD), manufactured by Bayer. The product is now indicated for use
August 20, 2020
August 20, 2020 – The U.S. FDA has approved Kesimpta® (ofatumumab), manufactured by Novartis, to treat adults who have relapsing forms of multiple sclerosis (MS), to include clinically
August 20, 2020
August 20, 2020 – Bayshore Pharmaceuticals has issued a voluntary recall of one lot of Metformin Hydrochloride Extended-Release (ER) Tablets USP, 500mg, as well as one lot of Metformin
August 20, 2020
August 20, 2020 – The U.S. FDA has approved expanded indications for Kyprolis® (carfilzomib – Amgen)
and Darzalex® (daratumumab – Genmab). The drugs may now be used together